Information Provided By: 
Fly News Breaks for October 5, 2018
SPLK
Oct 5, 2018 | 08:31 EDT
BMO Capital analyst Keith Bachman kept his Outperform rating and $133 price target on Splunk after attending its user conference, saying the double-digit growth in attendees to about 10K suggests that user interest in the platform remains high. The analyst also points to the positive feedback over Splunk's platform from its customers and partners and sees its offering as a "leader in data investigation and analytics". Bachman anticipates Splunk to continue expanding the use cases of its technology to drive increased customer demand.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
